Scientists Have Developed a Treatment to Delay Type 1 Diabetes Among People at High Risk

    4

    Type 1 diabetes develops when the immune system’s T cells mistakenly destroy the body’s own insulin-producing beta cells. The Teplizumab drugs targets cells to lessen the destruction of beta cells.